[1] Hofmann S R, Carlsson E, Kapplusch F, et al.Cyclic AMP Response Element Modulator-α Suppresses PD-1 Expression and Promotes Effector CD4+ T Cells in Psoriasis[J]. J Immunol, 2021, 207(1):55-64. [2] Niehues H, Krieken D, Ederveen T, et al. Antimicrobial Late Cornified Envelope Proteins:The Psoriasis Risk Factor Deletion of LCE3B/C Genes Affects Microbiota Composition[J]. J Invest Dermatol, 2021,S0022-202X(21):02618-X. [3] 刘爱民,李伟玲,陈宏翔,等.寻常型银屑病中医辨治新体系Delphi法专家问卷调查研究[J].北京中医药大学学报,2020,43(10):859-864. [4] Printy R, R Rivera㎡Yola,Czernik A , et al. Durable remissions of guttate psoriasis following short courses of IL inhibitors[J]. Int J Dermatol, 2021,60(9):1161-1162. [5] Nogueira M, Selores M, Torres T .A case of psoriasis and systemic lupus erythematous successfully treated with ustekinumab[J]. Eur J Dermatol, 2021, 31(3):429-431. [6] Linde A, Gerdts E, Tveit K S, et al.Subclinical cardiac organ damage in patients with moderate to severe psoriasis treated with infliximab[J]. J Clin Med, 2021,10(11):2440. [7] 中国中西医结合学会皮肤性病学专业委员会特色疗法学组.寻常型银屑病中医外治特色疗法专家共识(2017年)[J].中国中西医结合皮肤性病学杂志,2017,16(6):547-550. [8] 中华医学会皮肤性病学分会银屑病专业委员会.中国银屑病诊疗指南(2018完整版)[J].中华皮肤科杂志,2019,52(10):667-710. [9] 孟繁鹏,闫学文,刘栋,等.中医药治疗银屑病相关免疫机制研究进展[J].中国中西医结合皮肤性病学杂志,2020,19(1):101-103. [10] 秦岭,陈亚峰,秦万章.斑块状银屑病中医药治疗研究进展[J].中国中西医结合皮肤性病学杂志,2021,20(3):307-309. [11] 吴汶丰,张泽鑫,李玉清,等.银屑病共病的中医防治探讨[J].广州中医药大学学报,2021,38(5):1051-1054. [12] 李斌,李铮,杨文皓,等.走罐疗法治疗血瘀证斑块状银屑病皮损表皮增生的临床观察[J].中华中医药杂志,2021,36(2):1188-1191. [13] 姜桂仙,杨晓丽,周敏新.火针联合拔罐对静止期寻常型银屑病患者氧化应激、脂肪细胞因子和生活质量的影响[J].现代中西医结合杂志,2020,29(12):1294-1298,1363. [14] 运蓓蕾,林伟,刘悦.寻常型银屑病患者血清Lipocalin-2检测水平及与疾病活动性、炎症标志物、代谢指标的关系[J].中国实验诊断学,2021,25(1):39-42. [15] J Xia, Xie S Y , Liu K Q , et al. Systemic evaluation of the relationship between psoriasis,psoriatic arthritis and osteoporosis:observational and Mendelian randomisation study[J]. A Ann Rheum Dis, 2020,79(11):1460-1467. [16] 吴丹,刘敏,王晓哲.转录活化因子3、肿瘤转移相关蛋白1、低氧诱导因子-1α在银屑病患者中的表达及意义[J].中国实验诊断学,2020,24(1):134-137. |